Cancellations requested by the sponsor - regulatory actions

Sponsors can submit requests to cancel entries in the Australian Register of Therapeutic Goods (ARTG). The Therapeutic Goods Act 1989 (the Act) requires the TGA to publish information on the Secretary’s decision to action these cancellations.

The cancellation provisions relating to cancellations requested by the sponsor in the Act are:

  • cancellation of listed or registered therapeutic goods: section 30(1)(c)
  • cancellation of biologicals: section 32GA(1)(d)
  • cancellation of medical devices: section 41GL(d).

The records below include information on the cancellation decisions and any subsequent decisions to revoke such cancellations. To find out whether a product is currently authorised for supply in Australia, check the ARTG.

Enter a product name or an ARTG number.

Cancellations

Displaying 11 - 20 of 19776

Sandoz Pty Ltd

Product: CELECOXIB SZ celecoxib 200mg hard capsule blister pack

ARTG number: 210631

Type of decision: Cancelled under Section 30(1)(c) of the Act

Date of effect: 29 Jun 2018

Sandoz Pty Ltd

Product: CELECOXIB SZ celecoxib 100mg hard capsule blister pack

ARTG number: 210629

Type of decision: Cancelled under Section 30(1)(c) of the Act

Date of effect: 29 Jun 2018

Lupin Australia Pty Limited

Product: PERINDOPRIL/ INDAPAMIDE-GA 4/1.25 perindopril erbumine 4mg and indapamide hemihydrate1.25mg tablet blister pack

ARTG number: 208336

Type of decision: Cancelled under Section 30(1)(c) of the Act

Date of effect: 29 Jun 2018

Lupin Australia Pty Limited

Product: Levonorgestrel and ethinylestradiol Lupin 150/30 ED levonorgestrel 150 microgram and ethinylestradiol 30 microgram tablets blister pack

ARTG number: 205582

Type of decision: Cancelled under Section 30(1)(c) of the Act

Date of effect: 29 Jun 2018

Lupin Australia Pty Limited

Product: Levonorgestrel and ethinylestradiol LAPL 150/30 ED levonorgestrel 150 microgram and ethinylestradiol 30 microgram tablets blister pack

ARTG number: 205576

Type of decision: Cancelled under Section 30(1)(c) of the Act

Date of effect: 29 Jun 2018

Lupin Australia Pty Limited

Product: PERINDOPRIL-GA perindopril erbumine 8mg tablet blister pack

ARTG number: 203126

Type of decision: Cancelled under Section 30(1)(c) of the Act

Date of effect: 29 Jun 2018

Lupin Australia Pty Limited

Product: PERINDOPRIL-GA perindopril erbumine 4mg tablet blister pack

ARTG number: 203125

Type of decision: Cancelled under Section 30(1)(c) of the Act

Date of effect: 29 Jun 2018

Lupin Australia Pty Limited

Product: PERINDOPRIL-GA perindopril erbumine 2mg tablet blister pack

ARTG number: 203124

Type of decision: Cancelled under Section 30(1)(c) of the Act

Date of effect: 29 Jun 2018

Sandoz Pty Ltd

Product: Capecitabine Sandoz capecitabine 150mg film coated tablet bottle

ARTG number: 201799

Type of decision: Cancelled under Section 30(1)(c) of the Act

Date of effect: 29 Jun 2018

Sandoz Pty Ltd

Product: Capecitabine Sandoz capecitabine 500mg film coated tablet bottle

ARTG number: 201798

Type of decision: Cancelled under Section 30(1)(c) of the Act

Date of effect: 29 Jun 2018

Pages